Skip to content
Nicholas A. Saccomano

Nicholas A. Saccomano Ph.D.

Chief Executive Officer, OnKure Therapeutics

Nicholas A. Saccomano is currently the CEO of OnKure therapeutics, a precision oncology company in Boulder Colorado.  He is a…

Deborah Palestrant, Ph.D., M.B.A.

Deborah Palestrant, Ph.D., M.B.A.

Partner, 5AM Ventures and Executive Chair, 4:59 Initiative

Deborah Palestrant, Ph.D., M.B.A. joined 5AM Ventures in 2018 and is a Partner and Executive Chair of 4:59 Initiative. She…

Sean Harper, M.D.

Sean Harper, M.D.

Co-Founding Managing Director, Westlake Village BioPartners

Named by Time as one of the 50 most influential people in healthcare in 2018, Dr. Harper has helped bring…

Hyung Chun, M.D.

Director, Foresite Capital

Hyung is a seasoned physician-scientist who joined Foresite Capital in 2021 after being a member of the faculty at Yale…

Nancy Stagliano, Ph.D.

Nancy Stagliano, Ph.D.

Chair, Board of Directors

Nancy Stagliano, Ph.D., is CEO and chair of the board of Neuron23, Inc., a clinical-stage biotechnology company focused on developing…

Desmond Padhi, B.A., Pharm.D.

Desmond Padhi, Pharm.D.

Interim Chief Executive Officer

Desmond has more than 20 years of experience developing drugs across multiple therapeutic areas and brings a wealth of experience…

Back To Top